Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001104659-26-001478 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | PTGX | Waddill William D. | Dir | A - Grant | $0.00 | +2,695 | 7,825 | +53% | $0 |
| D | 2026-01-06 | 2026-01-02 | PTGX | Waddill William D. | Dir | A - Grant | $0.00 | +3,762 | 3,762 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | A | A | 2,695 | $0.00 | 7,825 | D | — | — | (F1) Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2026-01-02 | A | A | 3,762 | $0.00 | 3,762 | D | $87.18 · — to 2036-01-02 | 3,762 Common Stock | (F2) The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. |